Innovative Data and Analytics Platform to Accelerate Drug Development for Rare Diseases
Written by Laura Mullen on September 19, 2019
Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addressing the need to better characterize rare diseases.
TUCSON, Ariz. and WASHINGTON, September 19, 2019 — The Critical Path Institute… Read More